Возможно ли сохранение фертильности при рецидивах после консервативного лечения атипической гиперплазии и начального рака эндометрия
Olga V. Novikova, Е.Г. Новикова, К. В. Краснопольская et al. · 2019
The aim of this novel study was to evaluate the effectiveness of repeat conservative approach in reproductive age women previously hormonally treated for atypical hyperplasia (AH) and early endometrial cancer (EC). Twenty four patients who were initially diagnosed with AH and 33 with early EC made up for total of 57 patients with recurrences included in this study of whom 45 received hormonal therapy. Complete responses to this treatment were observed in 40 patients (89% total, 89% for AH and 88% for EC groups, not significantly different). Out of 20 patients cured and still interested in pregnancies 9 attempted IVF. Thirteen pregnancies were documented two of which resulted from IVF. The pregnancy rate was estimated to be 55% of those who attempted. Obstetric outcomes were as follows: 8 term labors (one of them was a twin delivery post IVF pregnancy), 2 missed abortions, one still birth at 27 weeks. Further observation revealed second recurrences in 25% of women with AH and EC (N=10). Conclusion: while second hormonal treatment for AH and EC recurrences results in cure in most women allowing them to conceive the risk of second recurrence is rather high.
Cited by 0 works.